FR2792201B1 - Procede du renforcement immunitaire et du developpement d'un transporteur lipidique pour une therapie genique anti-vih et anti-bacterienne - Google Patents
Procede du renforcement immunitaire et du developpement d'un transporteur lipidique pour une therapie genique anti-vih et anti-bacterienneInfo
- Publication number
- FR2792201B1 FR2792201B1 FR9904706A FR9904706A FR2792201B1 FR 2792201 B1 FR2792201 B1 FR 2792201B1 FR 9904706 A FR9904706 A FR 9904706A FR 9904706 A FR9904706 A FR 9904706A FR 2792201 B1 FR2792201 B1 FR 2792201B1
- Authority
- FR
- France
- Prior art keywords
- vitamin
- sulfate
- oxide
- chloride
- hiv
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9904706A FR2792201B1 (fr) | 1999-04-15 | 1999-04-15 | Procede du renforcement immunitaire et du developpement d'un transporteur lipidique pour une therapie genique anti-vih et anti-bacterienne |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9904706A FR2792201B1 (fr) | 1999-04-15 | 1999-04-15 | Procede du renforcement immunitaire et du developpement d'un transporteur lipidique pour une therapie genique anti-vih et anti-bacterienne |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2792201A1 FR2792201A1 (fr) | 2000-10-20 |
| FR2792201B1 true FR2792201B1 (fr) | 2001-11-02 |
Family
ID=9544419
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR9904706A Expired - Fee Related FR2792201B1 (fr) | 1999-04-15 | 1999-04-15 | Procede du renforcement immunitaire et du developpement d'un transporteur lipidique pour une therapie genique anti-vih et anti-bacterienne |
Country Status (1)
| Country | Link |
|---|---|
| FR (1) | FR2792201B1 (fr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2811566B1 (fr) * | 2000-07-13 | 2003-01-17 | Oreal | Composition, notamment cosmetique, renfermant la dhea et/ou ses precurseurs ou derives, et une vitamine |
| FR2818137B1 (fr) * | 2000-12-15 | 2006-07-28 | Oreal | Composition, notamment cosmetique, renfermant la 7-hydroxy dhea et/ou la 7-ceto dhea et au moins une vitamine et/ou un co-facteur enzymatique |
| FR2824738A1 (fr) * | 2001-05-21 | 2002-11-22 | Mcw Aids Res Ltd | Composition pharmaceutique et medicament pour le renforcement du systeme immunitaire notamment dans le traitement de l'infection par le virus vih |
| GB2396809A (en) * | 2003-01-03 | 2004-07-07 | Vitabiotics Ltd | Composition for the treatment of HIV and AIDS |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL194728C (nl) * | 1987-04-16 | 2003-01-07 | Hollis Eden Pharmaceuticals | Farmaceutisch preparaat geschikt voor de profylaxe of therapie van een retrovirale infectie of een complicatie of gevolg daarvan. |
| US4997851A (en) * | 1987-12-31 | 1991-03-05 | Isaacs Charles E | Antiviral and antibacterial activity of fatty acids and monoglycerides |
| US5753237A (en) * | 1989-09-25 | 1998-05-19 | University Of Utah Research Foundation | Method for augmenting immunological responses |
| US5686436A (en) * | 1993-05-13 | 1997-11-11 | Hiv Diagnostics, Inc. | Multi-faceted method to repress reproduction of latent viruses in humans and animals |
-
1999
- 1999-04-15 FR FR9904706A patent/FR2792201B1/fr not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| FR2792201A1 (fr) | 2000-10-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Pettifor et al. | Vitamin D deficiency and nutritional rickets in children | |
| Goodhart et al. | Modern nutrition | |
| Nielsen | The biological role of strontium | |
| EP0662825B1 (fr) | Complement multivitamine et mineral pour femmes enceintes | |
| WO2000023068A3 (fr) | Microcomprimes d'acide fumarique | |
| WO2006099233B1 (fr) | Compositions et methodes pour le traitement de l'osteoporose et des maladies articulaires inflammatoires | |
| YU54802A (sh) | Farmaceutska parenteralna kompozicija koja sadrži bifosfonat | |
| ES8500743A1 (es) | Procedimiento para preparar formas de mopidamol como granulados, granulos o tabletas | |
| IL130041A (en) | Ferric citrate and/or ferric acetate for controlling phosphate retention in hyperphosphatemia patients | |
| JP2007505886A (ja) | ２−メチレン−１９−ノル−ビタミンｄ誘導体及びビスホスフォネートの組み合わせを含む医薬組成物及び方法 | |
| WEISS et al. | Diphosphonate therapy in a patient with myositis ossificans progressiva | |
| FR2792201B1 (fr) | Procede du renforcement immunitaire et du developpement d'un transporteur lipidique pour une therapie genique anti-vih et anti-bacterienne | |
| PT92168B (pt) | Processo para a preparacao de composicoes farmaceuticas contendo derivados de nucleos de estrogenios para provocar a inibicao da actividade de esteroides sexuais | |
| ATE214613T1 (de) | Zusammensetzungen, die einen guggul-extrakt mit phosphatsalzen enthalten | |
| Whitson et al. | Severe hypocalcemia following bisphosphonate treatment in a patient with Paget's disease of bone | |
| GB2212722A (en) | Vitamin compositions | |
| JPS58501676A (ja) | 微量物質としてセレニウムをヒトに供給するための混合物、ならびに細胞培養のための培地中に器官を保存する溶液および血液成分を保存する栄養溶液におけるその使用 | |
| Smith | A surfeit of fluoride? | |
| Kinoshita et al. | Vitamin D insufficiency underlies unexpected hypocalcemia following high dose glucocorticoid therapy | |
| Gopal et al. | Symptomatic hypercalcemia of immobilization in a patient with end-stage renal disease | |
| Klein | Aluminum contamination of parenteral nutrition solutions and its impact on the pediatric patient | |
| US5665385A (en) | Dietary metal supplements | |
| WO2002043662A3 (fr) | Composition dietetique contenant de l'acide linoleique conjugue et du calcium pour une meilleure sante | |
| Infor | Infor | |
| Ragsdale et al. | Alendronate treatment to prevent osteoporotic fractures |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| TP | Transmission of property | ||
| ST | Notification of lapse | ||
| RN | Application for restoration | ||
| D3 | Decision to revoke the decision of lapse | ||
| ST | Notification of lapse | ||
| RN | Application for restoration | ||
| FC | Favourable decision of inpi director general on an application for restauration. | ||
| ST | Notification of lapse |
Effective date: 20051230 |